Renaissance Capital logo

A heady deal: Cannabis supplier Tilray prices IPO above the range at $17

July 18, 2018
TLRY

Tilray, a Canadian vertically integrated supplier of medical and recreational cannabis, raised $153 million by offering 9.0 million shares at $17, above the range of $14 to $16. Tilray plans to list on the Nasdaq under the symbol TLRY, and has the distinction of being the first cannabis producer to IPO on a US exchange. Cowen acted as lead manager on the deal.